ONCOLOGY Vol 16 No 11_Suppl_13 | Oncology

Managing Toxicities of High-Dose Interleukin-2

November 01, 2002

Although high-dose interleukin-2 (IL-2, Proleukin), a highly toxic agent used in the treatment of renal cell carcinoma and melanoma, was initially associated with treatment-related mortality, it can, in the appropriate